Products
Product news for May 2026
FluMist: flu protection without the injection In 2024, more than 2300 children were hospitalised in Australia with influenza, with almost half younger than 5 years.1 Previously healthy children can experience …
Product news for April Pain Supplement 2026
Pain relief that works differently1-3* Celebrex Relief (celecoxib 200mg) is a Pharmacist Only/S3 analgesic for customers suffering from acute pain due to muscle and joint injury, and period pain.1 With …
Product news for April 2026
Clinically proven sperm health Menevit was developed and clinically tested in Australia to help prevent oxidative stressors on sperm cells that can impact fertility. It was shown to statistically significantly …
Product news for March 2026
A unique eye lubricant NovaTears is a unique eye lubricant specifically designed for evaporative dry eye disease. It works by reducing excessive tear evaporation and stabilising the tear film to …
A new era of antioxidants for sensitive skin
Our skin follows a natural rhythm—protecting by day and repairing by night. But modern life disrupts this cycle. Daily exposure to pollution, UV, blue light, temperature changes and stress generates …
Product news for February 2026
A new option for travellers Help protect high-risk travellers aged 2 years and older with Dukoral, a simple and effective oral cholera vaccine. It offers 85% efficacy against clinical cholera …
Early start to 8CPA talks under consideration
Next CPA must be about “more than dispensing revenue”, Minister says Negotiations for the Eighth Community Pharmacy Agreement (8CPA) could be brought forward, in response to concerns around 60-day dispensing. …
Over-the-counter options for reflux: Gaviscon & Guardium
Troublesome symptoms of gastro-oesophageal reflux disease (GORD) affect approximately 14% of adults.1 While symptoms may vary from patient to patient, heartburn and acid regurgitation are the most commonly reported symptoms.2 …
Gerald Tracey: Collaborative care and supporting the transition to biosimilars
Rheumatologist, Dr Gerald Tracey explains the opportunities biosimilars present for prescribing physicians, particularly given the government supported streamlined process. Gerald highlights the advantages of collaborative care between the prescriber and …
Trent Twomey: The role of pharmacists and physicians in supporting a patient-centric narrative
Trent Twomey, the National President of the Pharmacy Guild of Australia highlights the shifting power dynamic from physicians to patients in determining what medicines they are prescribed. Collaborative care is …
Andrew Oster: The power of collaborative care in transitioning to biosimilars
Professor Andrew Oster, Consultant Rheumatologist at the Cabrini Medical Centre in Malvern, Victoria, explains the opportunities biosimilars bring, allowing patients to switch medications. Given the interchangeability of biosimilars, he emphasises …
Eric Chan: Cultivating a relationship of trust between pharmacist and physician
Head of Pharmacy at Blooms The Chemist, Eric Chan emphasises the importance of collaborative care in cultivating a relationship of trust and transparency between a pharmacist and physician. He outlines …